vision loss with tirzepatide Zepbound And Loss: An Informative And Helpful Patient Guide [2025] Ozempic and other weight-loss drugs

We want to understand the root cause of your weight stagnation or gain

Hims & Hers brought in $1.48 billion in revenue in 2024, up 69% year over year from $872 million in 2023, the company reported in its fourth-quarter and full-year earnings report

In this combined analysis, we observe that the degree of BMI loss depends strongly on sex, drug type, time on treatment and drug dosage, consistent with previous reports 11 , and has a relatively weak dependence on pre-treatment BMI (with higher starting BMI associated with greater BMI loss)

Monitor for emerging side effects, suicidal ideation (particularly in younger adults), or signs of serotonin syndrome, though the latter is rare with SSRI monotherapy